Welcome to our dedicated page for Dalrada Financl news (Ticker: DFCO), a resource for investors and traders seeking the latest updates and insights on Dalrada Financl stock.
Dalrada Financial Corporation (DFCO), now identified in company communications as Dalrada Technology Group, Inc., generates news across clean energy, semiconductor deposition technology, precision manufacturing, and health care. Its press releases highlight developments within core segments such as Dalrada Climate Technology, Deposition Technology (Deptec), and Genefic Specialty Pharmacy.
News related to clean energy and climate technology often covers contracts, distribution agreements, and facility developments involving Dalrada’s heat pump technology. Examples include agreements for heat pump installations in European light industrial facilities and a master distribution agreement in the United States that targets sales of commercial and residential heat pump units across multiple regions.
Updates from Deposition Technology (Deptec) focus on advanced thin-film deposition and semiconductor-related tools. Company announcements have detailed the availability of the proprietary Spectroptix plasma spectrometer for advance ordering, as well as the establishment of a manufacturing and R&D facility in Portland, Oregon, to support deposition technology production and sales in North America and beyond.
In the health care segment, news frequently centers on Genefic, Inc. and Genefic Specialty Pharmacy. Communications include interviews and updates that describe revenue growth, expansion of specialty pharmacy services, and the operation of licensed diagnostic laboratories and an infusion pharmacy.
Dalrada’s news flow also includes corporate and governance updates, such as changes to its board of directors, executive appointments, and the selection of independent registered public accounting firms. Together, these items provide insight into the company’s strategic direction, operational focus, and corporate evolution from Dalrada Financial Corporation (DFCO) to Dalrada Technology Group, Inc. (DHTI).
Dalrada Financial Corporation (DFCO) announced the appointment of Heather McMahon to its Clean Energy Advisory Board as part of its strategy to enhance cybersecurity within the Power and Utilities sector. With over two decades of experience, McMahon is expected to provide valuable insights on safeguarding energy infrastructure against cyber threats. CEO Brian Bonar emphasized the importance of cybersecurity for the firm's clean energy initiatives and ESG clients, highlighting the sector's vulnerability and the growing sophistication of cyber threats. Dalrada continues to innovate in clean energy and technology.
Dalrada Financial Corporation (OTCQB: DFCO) expands its executive leadership with the appointment of Jose Arrieta as Chief Strategy Officer and President of Dalrada Technologies. Arrieta, a seasoned executive with over 18 years of experience in various government sectors, will guide the company's growth strategy and oversee its subsidiaries. His past achievements include being instrumental in the selection of Dalrada’s Likido®ONE heat pump technology by the U.S. GSA and DOE, aimed at reducing greenhouse emissions.
Dalrada Corporation (OTCQB: DFCO) announced the addition of three experienced members to its Advisory Board: Reynold Bryan Jr., Capt. Patrick Blair, Ph.D., and John Short. These industry veterans bring expertise in medical research, healthcare management, and business development. The new board members will support Dalrada Health's initiatives to enhance its value-based healthcare model, aiming to improve patient outcomes nationally. CEO Brian Bonar emphasized that their leadership will help expand Dalrada's life sciences and consumer products sectors for affordable healthcare solutions.
Summary not available.
Dalrada Financial Corporation (OTCQB: DFCO) has appointed Dr. Elizabeth Ann Winzeler to its Dalrada Health advisory board. Dr. Winzeler's expertise in antimicrobial drug discovery is expected to enhance the company's healthcare initiatives. Dalrada aims to implement a national healthcare model, including traditional clinics and telemedicine, and plans to expand into the pharmaceutical sector rapidly. CEO Brian Bonar emphasizes the impact of Dr. Winzeler's experience on accelerating growth in the pharmaceutical market.
Dalrada Financial Corporation (OTCQB: DFCO) has expanded its executive team by appointing Brian McGoff as President and Chief Operating Officer. McGoff brings over 25 years of experience from reputable companies, emphasizing strategies for domestic and international growth. Chairman Brian Bonar welcomes him as a catalyst for driving growth and aligning products across Dalrada's sectors. McGoff aims to enhance business outcomes in health and clean energy, leveraging his extensive industry network and experience in diverse business operations.
Dalrada Corporation (DFCO) announced the acquisition of Watson Rx Solutions, Inc., marking a significant step in its growth strategy within the healthcare sector. This acquisition aims to develop a comprehensive healthcare solution by integrating pharmacy services with a range of patient care offerings, including telemedicine and testing facilities. CEO Brian Bonar emphasized the acquisition's potential to enhance patient care and expand Dalrada's healthcare footprint. The U.S. pharmaceutical market, valued at $300 billion in 2020, presents substantial growth opportunities.
Dalrada Corporation (OTCQB: DFCO) reported record financial growth for Q3 2022, achieving revenue of $5,592,150, a 252% increase from Q3 2021's $1,588,329. For nine months, revenue reached $15,641,766, up 458% year-over-year. The surge is primarily due to the COVID-19 testing segment and the sale of Likido® products. The company signed five contracts under its new Dalrada Energy Services division, promising further revenue growth. Major accomplishments include validation of Likido®ONE heat pumps by U.S. authorities and expansion in sales, positioning Dalrada for ongoing success.
Dalrada Corporation (OTCQB: DFCO) announced that its Likido®ONE heat pump has been selected by the US General Services Administration and Department of Energy for evaluation under the Green Proving Ground program. This initiative aims to reduce greenhouse emissions from commercial buildings. The Likido®ONE is a CO2-based heat pump that enhances efficiency and decarbonizes heating, addressing climate change challenges. Dalrada's technology aligns with federal efforts to adopt clean energy solutions while potentially reducing operational costs for commercial spaces.
Dalrada Corporation (OTCQB: DFCO) has successfully completed a second clinical trial of its cerVIA™ kit for cervical cancer screening in India, involving 100 women. The study faced delays due to COVID-19, with results published in the IJOPARB Journal. This trial showed the kit's accuracy at 91%, contributing to a significant public health goal: the WHO's aim to eliminate cervical cancer by 2030. The cerVIA™ kit is designed to enhance accessibility and reduce hospital visits, operational during a time when cancer screenings have notably declined globally.